NCT00038818View on ClinicalTrials.gov

CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation

NATerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions
Chronic Myelogenous LeukemiaMultiple MyelomaNon Hodgkin's LymphomaHodgkin's DiseaseChronic Lymphocytic Leukemia
Interventions
BIOLOGICAL

CD8 Depleted Donor Lymphocyte

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Eligix
All Listed Sponsors
collaborator

Eligix

UNKNOWN

lead

M.D. Anderson Cancer Center

OTHER